Oncology Research and Therapeutics
Oncology Research and Therapeutics focus on understanding cancer biology and developing innovative treatments to improve patient outcomes. In the short term, advancements in cancer research are accelerating progress in diagnostics, therapeutics, and personalized medicine.
Key Areas of Oncology Research:
-
Molecular and Genetic Understanding:
- Identifying genetic mutations, oncogenes, and tumor suppressor genes driving cancer progression.
- Exploring tumor microenvironment and immune system interactions.
-
Early Detection and Biomarkers:
- Developing liquid biopsies to detect circulating tumor DNA (ctDNA) or cancer biomarkers in blood.
- Improving imaging technologies for earlier and more accurate diagnosis.
Emerging Therapeutics in Oncology:
-
Immunotherapy:
- Checkpoint Inhibitors: Drugs targeting PD-1, PD-L1, or CTLA-4 pathways to unleash the immune response against cancer.
- CAR-T Cell Therapy: Engineering T cells to specifically attack cancer cells, showing success in blood cancers.
- Cancer Vaccines: Personalized vaccines stimulating immune responses to tumor-specific antigens.
-
Targeted Therapy:
- Small-molecule inhibitors targeting specific mutations, such as EGFR inhibitors for lung cancer or HER2 inhibitors for breast cancer.
- PARP inhibitors for cancers with BRCA mutations.
-
Precision Medicine:
- Tailoring treatments based on a patient’s genetic profile and the molecular characteristics of their tumor
Related Conference of Oncology Research and Therapeutics
Oncology Research and Therapeutics Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy
